VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT
Report
- Report Number
- 2210968-2025-06477
- Event Type
- Injury
- Date Received
- June 9, 2025
- Date of Event
- January 24, 2025
- Report Date
- June 9, 2025
- Manufacturer
- ETHICON INC.
- Product Code
- GAM
- PMA / PMN Number
- K022269
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- OTHER
Narratives
PRODUCT COMPLAINT # (B)(4). THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ETHICON INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ETHICON INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ANY OF THE ETHICON PRODUCTS INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? WHICH SPECIFIC ETHICON PRODUCTS HAVE BEEN USED DURING THE PROCEDURES (PRODUCT CODE, LOT NUMBER)? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH ANY OF THE ETHICON PRODUCTS USED IN THIS PROCEDURE? IF SO, PLEASE PROVIDE DETAILS. WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. PATIENT DEMOGRAPHICS? THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. H6 COMPONENT CODE: G07002 ¿ DEVICE NOT RETURNED. THE SINGLE COMPLAINT WAS REPORTED WITH MULTIPLE EVENTS. THERE ARE NO ADDITIONAL DETAILS REGARDING THE ADDITIONAL EVENTS. D4: UDI: AS THE CATALOG/MODEL NUMBER WAS NOT PROVIDED, THE (01) GTIN IS NOT AVAILABLE. CITATION: J PLAST RECONSTR AESTHET SURG. 2025 APR;103:316-323. HTTPS://DOI.ORG/10.1016/J.BJPS.2025.01.046. EPUB 2025 JAN 29. PMID: 40049036.
THIS COMPLAINT IS FROM A LITERATURE SOURCE. THE FOLLOWING LITERATURE CITE HAS BEEN REVIEWED: HEBEL N, MOHAN AT, EMANUELS A, WHITTY LA, MOIR C, BITE U. TISSUE EXPANSION AND HETEROLOGOUS MESH FOR ABDOMINAL WALL RECONSTRUCTION IN THE SURGICAL SEPARATION OF CONJOINED TWINS: A CASE SERIES. J PLAST RECONSTR AESTHET SURG. 2025 APR;103:316-323. DOI: 10.1016/J.BJPS.2025.01.046. EPUB 2025 JAN 29. PMID: 40049036. TITLE: TISSUE EXPANSION AND HETEROLOGOUS MESH FOR ABDOMINAL WALL RECONSTRUCTION IN THE SURGICAL SEPARATION OF CONJOINED TWINS: A CASE SERIES. THIS RETROSPECTIVE STUDY AIMS TO PRESENT AN OVERVIEW OF TISSUE EXPANSION IN THE RECONSTRUCTION AND SURGICAL CLOSURE OF VAST ABDOMINAL WALL DEFECTS AFTER CONJOINED TWIN SEPARATION AND A REPORT OF OUR CLINICAL EXPERIENCE. BETWEEN 1991 AND 2020, A TOTAL OF 4 PAIRS OF CONJOINED TWINS (3 FEMALES, 1 MALE) UNDERWENT ABDOMINAL SEPARATION, WHILE USING 2¿0 VICRYL FOR FASCIA CLOSURE, 3¿0 AND 4¿0 PROLENE FOR APPROXIMATION OF SUBCUTANEOUS TISSUE AND DERMIS, AND 4¿0 MONOCRYL FOR RUNNING SUBCUTICULAR SUTURES FOR SKIN. REPORTED COMPLICATIONS ARE 2¿0 VICRYL 3¿0 AND 4¿0 PROLENE 4¿0 MONOCRYL CASE 1 PERIUMBILICAL HERNIA N=1 TREATMENT: OBSERVATION CASE 2 N=1 TWIN A DELAYED HEALING OF EPIGASTRIUM TREATMENT: TREATED CONSERVATIVELY PERIUMBILICAL HERNIA TREATMENT: OBSERVATION CASE 3 N=1 TWIN A DELAYED HEALING OF EPIGASTRIUM TREATMENT: TREATED CONSERVATIVELY N=1 TWIN M IMMEDIATE ABDOMINAL COMPARTMENT SYNDROME TREATMENT: RECTIFIED WITH REDUCED TENSION CLOSURE RESPIRATORY INSUFFICIENCY N=1 TREATMENT: NOT REPORTED CASE 4 N=1 TWIN A1 DELAYED HEALING OF EPIGASTRIUM COMPLICATED BY A CANDIDA INFECTION TREATMENT: NOT REPORTED N=1 TWIN A2 PERIUMBILICAL HERNIA TREATMENT: SURGICAL CORRECTION WITH AUTOLOGOUS ABDOMINAL TISSUE AND PRE-EXISTING BIOLOGIC MESH IN CONCLUSION, IN OUR CASE SERIES, WE SHOW THE OPERATIVE TECHNIQUE AND SURGICAL MANAGEMENT FOR THE SEPARATION OF 4 CASES OF THORACOOMPHALOPAGUS TWINS. OUR PREFERRED SURGICAL METHOD OF SEPARATION SURROUNDS THE USE OF TISSUE EXPANDERS WITH MESH FASCIAL BOLSTERING FOR DEVELOPING ROBUST SOFT TISSUE FOR CLOSURE. WE OBSERVED FEW COMPLICATIONS AND PROPER WOUND CLOSURE IN ALL THE EXAMINED CASES SHOWED FURTHER PROOF OF TISSUE EXPANDER AND MESH VALIDITY IN THESE COMPLEX CASES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1333617 | VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT | SUTURE, ABSORBABLE, SYNTHETIC | GAM | ETHICON INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Other |